Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Zacks Research

Option Care Health (NASDAQ:OPCH) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Monday,Zacks.com reports.

OPCH has been the subject of several other reports. Weiss Ratings lowered Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday. National Bank Financial set a $37.00 price objective on Option Care Health in a report on Tuesday, January 27th. Wall Street Zen lowered Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. Barrington Research lowered their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $31.25.

Option Care Health Stock Performance

Shares of OPCH opened at $19.59 on Monday. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 15.19, a PEG ratio of 1.10 and a beta of 0.68. The stock has a 50 day moving average of $27.52 and a 200 day moving average of $30.43. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s revenue was up 1.3% on a year-over-year basis. During the same period last year, the business posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts forecast that Option Care Health will post 1.64 earnings per share for the current year.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Sullivan acquired 24,154 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were purchased at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the transaction, the director owned 73,383 shares in the company, valued at approximately $1,518,294.27. This represents a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 73,264 shares of company stock worth $1,548,316 in the last 90 days. Company insiders own 1.70% of the company’s stock.

Institutional Trading of Option Care Health

A number of hedge funds have recently made changes to their positions in the stock. Van Berkom & Associates Inc. bought a new stake in shares of Option Care Health in the 1st quarter worth approximately $42,739,000. Dimensional Fund Advisors LP lifted its position in Option Care Health by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after acquiring an additional 36,208 shares in the last quarter. KBC Group NV raised its stake in Option Care Health by 22.1% during the 1st quarter. KBC Group NV now owns 5,453 shares of the company’s stock valued at $147,000 after buying an additional 988 shares during the last quarter. Jennison Associates LLC raised its stake in Option Care Health by 4.2% during the 1st quarter. Jennison Associates LLC now owns 1,213,025 shares of the company’s stock valued at $32,655,000 after buying an additional 49,094 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in Option Care Health by 2,109.5% during the 1st quarter. Bessemer Group Inc. now owns 20,526 shares of the company’s stock valued at $553,000 after buying an additional 19,597 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.